azathioprine has been researched along with Coronary Restenosis in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arruda, JA | 1 |
Costa, MA | 1 |
Brito, FS | 1 |
Tedesco, H | 1 |
Barbosa, AH | 1 |
Ribeiro, EP | 1 |
Pestana, JO | 1 |
Lima, VC | 1 |
1 trial available for azathioprine and Coronary Restenosis
Article | Year |
---|---|
Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients.
Topics: Azathioprine; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Cyclosporine; Drug Therap | 2003 |